Inventor
ANKER STEFAN
DE16 patents
⚠️ This page may combine multiple inventors who share the name “ANKER STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACTIMED THERAPEUTICS LTD
9 patentsUS10828270B2Nov 10, 2020
Oxprenolol compositions for treating cancer
ACTIMED THERAPEUTICS LTD1 citations69
US10398658B2Sep 3, 2019
Oxprenolol compositions for treating cancer
ACTIMED THERAPEUTICS LTD1 citations69
US12303474B2May 20, 2025
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
ACTIMED THERAPEUTICS LTD0 citations59
US11938102B2Mar 26, 2024
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
ACTIMED THERAPEUTICS LTD0 citations59
US11433036B2Sep 6, 2022
Oxprenolol compositions for treating cancer
ACTIMED THERAPEUTICS LTD0 citations59
US11382876B2Jul 12, 2022
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
ACTIMED THERAPEUTICS LTD0 citations59
US11096908B2Aug 24, 2021
S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
ACTIMED THERAPEUTICS LTD0 citations59
US11007158B2May 18, 2021
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
ACTIMED THERAPEUTICS LTD0 citations59
US10449166B2Oct 22, 2019
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
ACTIMED THERAPEUTICS LTD0 citations48
BERGMANN ANDREAS
2 patentsUS8252544B2Aug 28, 2012
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients
BERGMANN ANDREAS13 citations83
US8647830B2Feb 11, 2014
Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease
BERGMANN ANDREAS5 citations72